Unknown

Dataset Information

0

Primaquine clears submicroscopic Plasmodium falciparum gametocytes that persist after treatment with sulphadoxine-pyrimethamine and artesunate.


ABSTRACT:

Background

P. falciparum gametocytes may persist after treatment with sulphadoxine-pyrimethamine (SP) plus artesunate (AS) and contribute considerably to malaria transmission. We determined the efficacy of SP+AS plus a single dose of primaquine (PQ, 0.75 mg/kg) on clearing gametocytaemia measured by molecular methods.

Methodology

The study was conducted in Mnyuzi, an area of hyperendemic malaria in north-eastern Tanzania. Children aged 3-15 years with uncomplicated P. falciparum malaria with an asexual parasite density between 500-100,000 parasites/microL were randomized to receive treatment with either SP+AS or SP+AS+PQ. P. falciparum gametocyte prevalence and density during the 42-day follow-up period were determined by real-time nucleic acid sequence-based amplification (QT-NASBA). Haemoglobin levels (Hb) were determined to address concerns about haemolysis in G6PD-deficient individuals.

Results

108 individuals were randomized. Pfs25 QT-NASBA gametocyte prevalence was 88-91% at enrolment and decreased afterwards for both treatment arms. Gametocyte prevalence and density were significantly lower in children treated with SP+AS+PQ. On day 14 after treatment 3.9% (2/51) of the SP+AS+PQ treated children harboured gametocytes compared to 62.7% (32/51) of those treated with SP+AS (p<0.001). Hb levels were reduced in the week following treatment with SP+AS+PQ and this reduction was related to G6PD deficiency. The Hb levels of all patients recovered to pre-treatment levels or greater within one month after treatment.

Conclusions

PQ clears submicroscopic gametocytes after treatment with SP+AS and the persisting gametocytes circulated at densities that are unlikely to contribute to malaria transmission. For individuals without severe anaemia, addition of a single dose of PQ to an efficacious antimalarial drug combination is a safe approach to reduce malaria transmission following treatment.

Trial registration

Controlled-Trials.com ISRCTN61534963.

SUBMITTER: Shekalaghe S 

PROVIDER: S-EPMC1995753 | biostudies-literature | 2007 Oct

REPOSITORIES: biostudies-literature

altmetric image

Publications

Primaquine clears submicroscopic Plasmodium falciparum gametocytes that persist after treatment with sulphadoxine-pyrimethamine and artesunate.

Shekalaghe Seif S   Drakeley Chris C   Gosling Roly R   Ndaro Arnold A   van Meegeren Monique M   Enevold Anders A   Alifrangis Michael M   Mosha Frank F   Sauerwein Robert R   Bousema Teun T  

PloS one 20071010 10


<h4>Background</h4>P. falciparum gametocytes may persist after treatment with sulphadoxine-pyrimethamine (SP) plus artesunate (AS) and contribute considerably to malaria transmission. We determined the efficacy of SP+AS plus a single dose of primaquine (PQ, 0.75 mg/kg) on clearing gametocytaemia measured by molecular methods.<h4>Methodology</h4>The study was conducted in Mnyuzi, an area of hyperendemic malaria in north-eastern Tanzania. Children aged 3-15 years with uncomplicated P. falciparum m  ...[more]

Similar Datasets

| S-EPMC3697316 | biostudies-other
| S-EPMC5857106 | biostudies-literature
| S-EPMC7353807 | biostudies-literature
| S-EPMC1513405 | biostudies-literature
| S-EPMC5547055 | biostudies-literature
| S-EPMC5498763 | biostudies-literature
| S-EPMC4649191 | biostudies-literature
| S-EPMC3444377 | biostudies-literature
| S-EPMC3390272 | biostudies-literature
| S-EPMC2923188 | biostudies-literature